We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

INTERVIEW: MHRA chief Ian Hudson on the hot topics in pharma, Part 1

News

Executive Summary

When Scrip Regulatory Affairs editor Maureen Kenny interviewed Ian Hudson, the chief executive of the UK Medicines and Healthcare Products Regulatory Agency had just got back from an official trip to India. We asked Dr Hudson how the trip had gone and questioned him about a host of other pharmaceutical-related regulatory topics including international initiatives to promote co-operation on inspections; changing faces among the heads of EU medicines agencies; evolving workload patterns at the MHRA, the new EU Clinical Trials Regulation, the agency's activities in the area of Ebola… and the possibility that the UK might ultimately leave the EU.